# PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis

> **NCT04886726** · PHASE1 · RECRUITING · sponsor: **Henry Ford Health System** · enrollment: 18 (estimated)

## Conditions studied

- Graft Versus Host Disease

## Interventions

- **DRUG:** uhCG/EGF

## Key facts

- **NCT ID:** NCT04886726
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-23
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04886726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04886726, "PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04886726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*